Boerhinger funds ADA initiative

Share this article:

Boehringer Ingelheim is sponsoring a collaborative research project with the American Diabetes Association to improve the evidence base for and clinical care of patients with chronic kidney disease and diabetes.

The three-year commitment includes $1.5 million from Boehringer, which will be managed by the ADA.

“Diabetes is the leading cause of kidney failure, accounting for more than 40% of new cases,” the American Diabetes Association's president of medicine and science Elizabeth Seaquist said in a statement.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.